|
Volumn 31, Issue 11, 2004, Pages 1634-1636
|
Anti-apoptosis protein, survivin-2B-derived peptide vaccine therapy
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BIRC5 PROTEIN, HUMAN;
CANCER VACCINE;
MICROTUBULE ASSOCIATED PROTEIN;
TUMOR MARKER;
TUMOR PROTEIN;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COLORECTAL TUMOR;
FEMALE;
HUMAN;
IMMUNOLOGY;
MALE;
MIDDLE AGED;
PHASE 2 CLINICAL TRIAL;
TREATMENT OUTCOME;
VACCINATION;
ADULT;
AGED;
CANCER VACCINES;
COLORECTAL NEOPLASMS;
FEMALE;
HUMANS;
MALE;
MICROTUBULE-ASSOCIATED PROTEINS;
MIDDLE AGED;
NEOPLASM PROTEINS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
VACCINATION;
|
EID: 16544370499
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|